Figma Shares Indicated To Open $105/$110
LONDON - Ondine Biomedical Inc. (AIM:OBI), a healthcare technology company, has announced its schedule for the release of its audited Full Year Results for the year ended December 31, 2024. The results and the company’s Annual Report 2024 will be made public on May 15, 2025. Following the release, Dr. Nicolas Loebel, President and Chief Technology Officer, will conduct a live presentation via Investor Meet Company at 16:30 BST on the same day.
The event is designed to be accessible to all interested parties, including current and prospective shareholders of Ondine Biomedical. Attendees will have the opportunity to submit questions ahead of the live session until 09:00 BST on May 14, 2025, or they can pose questions during the presentation itself.
Ondine Biomedical has facilitated the registration process for investors who wish to join the presentation. They can sign up at no cost through the Investor Meet Company platform and add Ondine Biomedical to their list of interests. Those who are already following the company on the platform will receive automatic invitations to the event.
The Annual Report 2024, which will offer a comprehensive overview of the fiscal year, will be available on the company’s website. Additionally, the presentation slides and a recording of the live session will be posted online for public access by no later than May 16, 2025.
This announcement is based on a press release statement from Ondine Biomedical Inc. The company’s forthcoming disclosure of its financial results will provide stakeholders with detailed insights into its performance over the past year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.